SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.87%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$671M
AUM Growth
+$671M
(-4.5%)
Cap. Flow
-$75.2M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
36.87%
Holding
176
New
35
Increased
31
Reduced
45
Closed
50
Top Buys
| 1 |
Biogen
BIIB
|
$20.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 3 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
$9.03M |
| 4 |
BCOM
B Communications Ltd
BCOM
|
$6.45M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$5.32M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 2 |
Perrigo
PRGO
|
$16.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13.3M |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$12.5M |
| 5 |
Amgen
AMGN
|
$9.21M |
Sector Composition
| 1 | Healthcare | 77.22% |
| 2 | Technology | 6.01% |
| 3 | Utilities | 2.06% |
| 4 | Industrials | 1.46% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
76
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.16M | 0.31% | +100,000 | New | +$3.16M |
|
|
PAY
77
DELISTED
Verifone Systems Inc
PAY
| $3.16M | 0.31% | 93,055 +17,510 | +23% | +$595K |
|
78
uniQure
QURE
$896M
| $3.11M | 0.3% | 115,000 +12,585 | +12% | +$340K |
|
|
FPRX
79
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.11M | 0.3% | +125,000 | New | +$3.11M |
|
|
AGTC
80
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.07M | 0.3% | 200,124 -35,000 | -15% | -$537K |
|
|
MLNX
81
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $3.05M | 0.3% | +62,850 | New | +$3.05M |
|
82
Arbutus Biopharma
ABUS
$711M
| $3.02M | 0.3% | 255,000 -43,486 | -15% | -$516K |
|
|
MRTX
83
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.99M | 0.29% | 95,000 -5,000 | -5% | -$157K |
|
84
Apple
AAPL
$3.45T
| $2.91M | 0.29% | 23,223 -19,510 | -46% | -$2.45M |
|
|
IMDZ
85
DELISTED
Immune Design Corp.
IMDZ
| $2.89M | 0.28% | 140,000 +10,560 | +8% | +$218K |
|
86
Starbucks
SBUX
$100B
| $2.87M | 0.28% | 53,583 -33,725 | -39% | -$1.81M |
|
87
KalVista Pharmaceuticals
KALV
$678M
| $2.86M | 0.28% | +400,000 | New | +$2.86M |
|
88
WIX.com
WIX
$7.85B
| $2.84M | 0.28% | +120,305 | New | +$2.84M |
|
89
Cytokinetics
CYTK
$4.23B
| $2.84M | 0.28% | +422,250 | New | +$2.84M |
|
|
CLCD
90
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $2.82M | 0.28% | +317,250 | New | +$2.82M |
|
91
Ionis Pharmaceuticals
IONS
$6.79B
| $2.76M | 0.27% | +48,000 | New | +$2.76M |
|
92
SCYNEXIS
SCYX
$34.9M
| $2.75M | 0.27% | +313,000 | New | +$2.75M |
|
|
OTIC
93
DELISTED
Otonomy, Inc.
OTIC
| $2.6M | 0.25% | 113,000 +43,000 | +61% | +$989K |
|
|
TRVN
94
DELISTED
Trevena, Inc.
TRVN
| $2.57M | 0.25% | 410,000 +18,189 | +5% | +$114K |
|
95
Ellomay Capital Ltd
ELLO
$239M
| $2.52M | 0.25% | 246,697 +25,019 | +11% | +$255K |
|
96
Snap-on
SNA
$17B
| $2.44M | 0.24% | 15,340 | – | – |
|
|
TBRA
97
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $2.37M | 0.23% | +137,622 | New | +$2.37M |
|
|
TTPH
98
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.35M | 0.23% | 49,500 -25,500 | -34% | -$1.21M |
|
99
Summit Therapeutics
SMMT
$17.6B
| $2.28M | 0.22% | 205,200 +30,200 | +17% | +$336K |
|
|
PTN
100
DELISTED
Palatin Technologies
PTN
| $2.26M | 0.22% | 2,540,266 +1,500,000 | +144% | +$1.34M |
|